title: [Diagnostic value of lipids and apolipoproteins for assessment of atherogenic risk].
abstract: In 242 coronarographed male patients (51.7 +/- 7.6 years) with 0-, 1-, 2- or 3-vessel diseases as well as a clinically healthy control group (n = 68, 50.6 +/- 8.5 years) the lipoprotein pattern was investigated: total-, LDL-, HDL-, HDL2-, HDL3-, beta-, pre-beta-alpha-cholesterol, triglycerides, apolipoproteins (Apo) A-I, A-II, B, (A-I)HDL, Lp(a). With regard to the separation of patients with diseases of the coronary vessels and healthy persons out of the individual parameters Apo A-I (turbidimetrically), HDL3 and HDL cholesterol had the greatest significance (maximal diagnostic efficiency: 0.81, 0.76, 0.72). For the assessment of the severity of the change of the coronary vessels the quotient total/HDL cholesterol was most suitable (efficiency: 0.67). Differences in the diagnostic significance were established in the determination of a parameter by means of different methods. The intake of beta-receptor blockers increased the concentration of the triglycerides and pre-beta-cholesterol.
authors: Bezirkskrankenhauses Meiningen, Zentralklinik für Herz- Lungenkrankheiten, Bad Berka.
authors: W
authors: W
authors: Herrmann
authors: S
authors: S
authors: Hanf
authors: C
authors: C
authors: Schütz
authors: H G
authors: HG
authors: Lindhofer
authors: H
authors: H
authors: Schmidt
authors: H J
authors: HJ
authors: Strauss
authors: H
authors: H
authors: Schaedel
authors: B
authors: B
authors: Oswald
mesh_terms: D001053:Apolipoproteins / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D001053:Apolipoproteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008055:Lipids; D008074:Lipoproteins
vernacular_title: Zur diagnostischen Wertigkeit von Lipiden und Apolipoproteinen für die Beschreibung des atherogenen Risikos.